Abstract
C3H10N3O5V, monoclinic, P21/c (no. 14), a = 5.487(2) Å, b = 7.611(3) Å, c = 19.629(8) Å, β = 101.269(11)°, V = 803.9(5) Å3, Z = 4, R gt (F) = 0.0375, wRref(F2) = 0.0866, T = 293(2) K.
The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.
Crystal: | Colorless block |
Size: | 0.20 × 0.18 × 0.16 mm |
Wavelength: | Mo Kα radiation (0.71073 Å) |
μ: | 1.23 mm−1 |
Diffractometer, scan mode: | Xcalibur, φ and ω |
θmax, completeness: | 27.7°, 99% |
N(hkl)measured, N(hkl)unique, Rint: | 5226, 1886, 0.036 |
Criterion for Iobs, N(hkl)gt: | Iobs > 2 σ(Iobs), 1413 |
N(param)refined: | 136 |
Programs: | Bruker [1], SHELX [2], WinGX/ORTEP [3], PLATON [4] |
Atom | x | y | z | Uiso*/Ueq |
---|---|---|---|---|
V1 | 0.61055 (8) | 0.56706 (6) | 0.82000 (2) | 0.02664 (14) |
O1 | 0.7704 (3) | 0.6556 (3) | 0.74914 (10) | 0.0350 (5) |
O2 | 0.5665 (3) | 0.7983 (3) | 0.85368 (9) | 0.0337 (5) |
O3 | 0.3389 (3) | 0.5270 (3) | 0.77583 (10) | 0.0365 (5) |
O4 | 0.9655 (3) | 0.5606 (3) | 0.89033 (9) | 0.0320 (4) |
O5 | 1.2450 (4) | 0.4009 (3) | 0.96115 (11) | 0.0468 (6) |
N1 | 0.8063 (4) | 0.4736 (3) | 0.75089 (12) | 0.0317 (5) |
H1A | 0.959260 | 0.434566 | 0.767578 | 0.038* |
H1B | 0.723658 | 0.411610 | 0.715312 | 0.038* |
N2 | 0.4977 (4) | 0.6800 (3) | 0.90072 (11) | 0.0323 (5) |
H2A | 0.336702 | 0.672726 | 0.901933 | 0.039* |
H2B | 0.597866 | 0.670738 | 0.942087 | 0.039* |
N3 | 0.6189 (5) | 0.3185 (4) | 0.87021 (15) | 0.0359 (6) |
H3Aa | 0.536517 | 0.326349 | 0.904912 | 0.043* |
H3Ba | 0.541288 | 0.239746 | 0.840061 | 0.043* |
H3Ib | 0.488 (12) | 0.333 (8) | 0.895 (3) | 0.043* |
H3Jb | 0.597 (13) | 0.252 (10) | 0.846 (4) | 0.043* |
C1 | 1.0378 (5) | 0.4196 (4) | 0.92227 (14) | 0.0357 (7) |
C2a | 0.8744 (16) | 0.2564 (13) | 0.8980 (5) | 0.035 (2) |
H2Ca | 0.937856 | 0.201243 | 0.859828 | 0.042* |
C3a | 0.8743 (18) | 0.1204 (10) | 0.9533 (4) | 0.072 (3) |
H3Ca | 0.768939 | 0.024326 | 0.934521 | 0.108* |
H3Da | 0.813440 | 0.171637 | 0.991423 | 0.108* |
H3Ea | 1.040522 | 0.078215 | 0.969320 | 0.108* |
C2Bb | 0.8508 (14) | 0.2700 (11) | 0.9214 (4) | 0.028 (2) |
H2Db | 0.817806 | 0.244313 | 0.967643 | 0.034* |
C3Bb | 0.9760 (12) | 0.1170 (9) | 0.8915 (4) | 0.051 (2) |
H3Fb | 0.872578 | 0.014535 | 0.889057 | 0.076* |
H3Gb | 1.133923 | 0.093329 | 0.920991 | 0.076* |
H3Hb | 1.000302 | 0.146827 | 0.845822 | 0.076* |
-
aOccupancy: 0.484 (9), bOccupancy: 0.516 (9).
Source of material
All reagents were obtained from commercial sources and used without further purification. The compound was synthesized by aqueous reactions: NH4VO3 (1.72 mmol), alanine (5.00 mmol) and NaOH (6.61 mmol) was dissolved in 12 mL of aqueous solution at room temperature. The resulting yellow solution was cooled to 275 K in an ice bath. NH2OH…HCl (4.31 mmol) was added slowly with constant stirring. The pH of the solution was about 6.5. The obtained yellow solution was filtered. Colorless crystals were obtained by slow evaporation of the filtrate from ethanol at 277 K for a few days. Anal. Calcd. for C3H10N3O5V (%): C, 16.45; H, 4.60; N, 19.18; V, 23.25. Found: C, 16.51; H, 4.56; N, 19.20; V, 23.22. The vanadium content was determined by spectrophotometry.
Experimental details
The structure was solved by direct methods with the SHELXS-2018 program [2]. The H atoms bonded to N3 atoms were located in difference maps and refined freely. Other H atoms were placed in calculated positions. The Carbon atoms C2 and C3 are disordered over two positions.
Comment
Vanadium is a trace element in biochemical systems to play an important role in metalloenzymes and impact insulin regulation [5]. In recent years, a number of vanadium hydroxylamido complexes have shown that the hydroxylamido ligand coordinates in a side-on manner as does the peroxo functionality [6]. To the best of our knowledge, the coordination chemistry of vanadium hydroxylamine complexes has been less studied so far [7], [8], [9]. Therefore, we have synthesized the title compound, and report crystal structure.
In the crystal structure of the title compound the vanadium(V) centers are seven-coordinated in pentagonal bipyramidal geometry containing two bidentate hydroxylamido ligands, one oxido, and one alaninato ligand. The two hydroxylamine molecules and the amine nitrogen atom of alanine molecule define a pentagonal equatorial plane approximately perpendicular to V=O bond, while the two oxygen atoms [O3, O4] occupy the axial position, and the distance of vanadium from the equatorial plane is 0.238 Å. The hydroxylamido ligands are coordinated with the nitrogen atoms cis to the alaninato ligand. The carboxylate oxygen atom of alanine is coordinated trans to the oxido group in the complex, the V–N bond lengths are 2.018(2) and 2.004(2) Å, respectively, and the V–O bond lengths are 1.906(2) and 1.912(2) Å, respectively. The molecular structure of the compound is very similar to the other vanadium(V) hydroxylamido complexes with amino acid ligands [10, 11].
Funding source: Natural Science Foundation of Heilongjiang Province of China
Award Identifier / Grant number: LH2019B029
-
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
-
Research funding: This study was financially supported by the Department of Science and Technology of Natural Science Foundation of Heilongjiang Province of China (LH2019B029).
-
Conflict of interest statement: The authors declare no conflicts of interest regarding this article.
References
1. BRUKER. SAINT, APEX2 and SADABS; Bruker AXS Inc.: Madison, Wisconsin, USA, 2008.Search in Google Scholar
2. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Search in Google Scholar
3. Farrugia, L. J. WinGX and ORTEP for Windows: an update. J. Appl. Crystallogr. 2012, 45, 849–854; https://doi.org/10.1107/s0021889812029111.Search in Google Scholar
4. Spek, A. L. Structure validation in chemical crystallography. Acta Crystallogr. 2009, D65, 148–155; https://doi.org/10.1107/s090744490804362x.Search in Google Scholar
5. Crans, D. C., Smee, J. J., Gaidamauskas, E., Yang, L. Q. The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds. Chem. Rev. 2004, 104, 849–902; https://doi.org/10.1021/cr020607t.Search in Google Scholar
6. Smee, J. J., Epps, J. A., Ooms, K., Bolte, S. E., Polenova, T., Baruah, B., Yang, L. Q., Ding, W. J., Li, M., Willsky, G. R., la Cour, A., Anderson, O. P., Crans, D. C. Chloro-substituted dipicolinate vanadium complexes: synthesis, solution, solid-state, and insulin-enhancing properties. J. Inorg. Biochem. 2009, 103, 575–584; https://doi.org/10.1016/j.jinorgbio.2008.12.015.Search in Google Scholar
7. Arrambide, G., Gambino, D., Baran, E. Synthesis and spectroscopic characterization of hydroxylamido/amino acid complexes of oxovanadium(V). J. Coord. Chem. 2009, 62, 63–74; https://doi.org/10.1080/00958970802474821.Search in Google Scholar
8. Crans, D. C., Smee, J. J., Gaidamauskiene, E. G., Anderson, O. P., Miller, S. M., Jin, W. Z., Gaidamauskas, E., Crubellier, E., Grainda, R., Chi, L. H., Willsky, G. R. Inhibition of yeast growth by molybdenum-hydroxylamido complexes correlates with their presence in media at differing pH values. J. Inorg. Biochem. 2004, 98, 1837–1850; https://doi.org/10.1016/j.jinorgbio.2004.08.010.Search in Google Scholar
9. Keramidas, A. D., Miller, S. M., Anderson, O. P., Crans, D. C. Vanadium(V) hydroxylamido complexes: solid state and solution properties. J. Am. Chem. Soc. 1997, 119, 8901–8915; https://doi.org/10.1021/ja970747y.Search in Google Scholar
10. Zhang, H. Q., Zhang, Q. Y., Li, J., Liu, D., Wu, X. F., Shan, Y. K. Synthesis, characterization and PTP1B inhibitory activity of the vanadium complexes with amino-acids. Chem. J. Chin. Univ. 2012, 33, 243–250.Search in Google Scholar
11. Li, L. Z., Xu, T., Wang, D. Q. Synthesis and crystal structure of two vanadium(V) hydroxylamido complexes with amino acid ligands. J. Chem. Crystallogr. 2004, 34, 585–590; https://doi.org/10.1023/b:jocc.0000044084.32526.8d.10.1023/B:JOCC.0000044084.32526.8dSearch in Google Scholar
© 2022 Heng-Qiang Zhang et al., published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution 4.0 International License.